LoadingLoadingLoadingNet selling: insiders sold $6.1M and bought $0 on the open market in 90 days (SEC Form 4). Congress: net selling of $203K to $495K in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsEach bar is 100% of that source’s money. The notch marks an even split.
Lean is the direction of the latest moves. Descriptive, not advice.
Buys/Adds (2)
Harris Associates
$551.4M
added
PRIMECAP
$233.1M
added
Sells/Trims (1)
D.E. Shaw
$160.1M
trimmed
No tracked top-trader positions in MRSH as of Oct 24, 09:34 UTC.
Hyperliquid positioning - not every stock is covered
Last report
Oct 15, 2026
Financial period
Q3 2026
Earnings per share
$1.96 expected
Revenue
$6.64B expected
Estimates as of Oct 21, 2026
EPS expected
$2.12 to $2.28
Revenue expected
12 analysts
Last 30 days
Analysts raising estimates
Estimate drift
Change in 30 days
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Sep 30, 2026 | Oct 15, 2026 | $2.03 / $1.96Alpha Vantage | +3.57% beat | $6.86B $6.64B expected | +3.30% beat |
| Jun 30, 2026 | Jul 21, 2026 | $2.96 / $2.88Alpha Vantage | +2.78% beat | $7.40B No estimate | Unavailable |
| Mar 31, 2026 | Apr 16, 2026 | $3.29 / $3.22Alpha Vantage | +2.17% beat | $7.60B No estimateSEC filing | Unavailable |
| Dec 31, 2025 | Jan 29, 2026 | $2.12 / $1.97Alpha Vantage | +7.61% beat | $6.59B No estimate | Unavailable |
| Sep 30, 2025 | Oct 16, 2025 | $1.85 / $1.78Alpha Vantage | +3.93% beat | $6.35B No estimateSEC filing | Unavailable |
| Jun 30, 2025 | Jul 17, 2025 | $2.72 / $2.66Alpha Vantage | +2.26% beat | $6.97B No estimateSEC filing | Unavailable |
| Mar 31, 2025 | Apr 17, 2025 | $3.06 / $3.00Alpha Vantage | +2.00% beat | $7.06B No estimateSEC filing | Unavailable |
| Dec 31, 2024 | Jan 30, 2025 | $1.87 / $1.76Alpha Vantage | +6.25% beat | $6.07B No estimate | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
| USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $6.59B | $7.60B | $7.40B | $6.86B |
| Cost of what it sold | $3.94B | $4.13B | $4.14B | $4.08B |
| Gross profit | $2.66B | $3.47B | $3.26B | $2.79B |
| What it spent | ||||
| Other operating costs | $1.44B | $1.71B | $1.36B | $1.57B |
| Total operating expenses | $1.44B | $1.71B | $1.36B | $1.57B |
| What was left | ||||
| Operating profit | $1.22B | $1.75B | $1.90B | $1.22B |
| Interest on debt | $235.0M | $240.0M | $250.0M | $248.0M |
| Profit before tax | $1.06B | $1.58B | $1.70B | $1.03B |
| Tax | $222.0M | $395.0M | $411.0M | $221.0M |
| Net profit | $821.0M | $1.15B | $1.27B | $808.0M |
| EBITDA | $1.50B | $1.57B | $1.43B | $1.51B |
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is bullish
Marsh & McLennan Lobbies Reauthorization Bills
NeutralOct 22Marsh & McLennan stock hits 52-week high at 198.5 USD
BullishOct 2211,804 Marsh & McLennan Companies, Inc. $MRSH Shares Purchased by Integrated Advisors Network LLC
Leans bullishOct 22Hosking Partners LLP Makes New Investment in Marsh & McLennan Companies, Inc. $MRSH
Leans bullishOct 22Marsh & McLennan Companies, Inc. $MRSH Stock Sold by Assenagon Asset Management S.A.
NeutralOct 22Marsh & McLennan Companies, Inc. (MRSH) Stock Price, News, Quote & History
NeutralOct 21Robeco Institutional Asset Management B.V. Purchases 201,056 Shares of Marsh & McLennan Companies, Inc. $MRSH
Leans bullishOct 21Marsh & McLennan Companies, Inc. Actuals & Estimates (XETR:MSN)
Leans bullishOct 21
